期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | RESPIRATORY RESEARCH LetPub Score 7.2
50 ratings
Rate
Reputation 8.3 Influence 6.3 Speed 7.0 | ||||||||||||||||
期刊簡稱 | RESP RES | ||||||||||||||||
ISSN | 1465-993X | ||||||||||||||||
h-index | 89 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 4.30%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/journal/12931 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/RERE | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||
主題領域 | RESPIRATORY SYSTEM | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 2000 | ||||||||||||||||
每年文章數 | 285每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 99.79% | ||||||||||||||||
OA Related Info | APC: Yes( GBP2490; USD3290; EUR2790; ) APC waiver:Check Notes Other charges: No Keywords: respiratory diseases、respiratory medicine、pulmonology、immunology、allergy Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1465-993X%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[RESPIRATORY RESEARCH] 的評論 | 撰寫評論 |
作者: 东京婉奕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-03 12:02:27 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Focused research direction: lung cancer; experience sharing in bioinformatics analysis: Submitted on 20230913, under review on 20230914, first review returned on 20231012, major revision required according to two reviewers on 20231211, resubmitted to journal on 20231224, second review returned with minor revision required on 20240103, resubmitted to journal on 20240118, accepted on 202402. Overall, the speed of review is considered relatively fast. The articles accepted have a combination of bioinformatics and simple validation (immunohistochemistry + clinical cohorts). Considering other comments on slow review speed, it can be boldly speculated that the efficiency of handling manuscripts by different editors varies greatly(0) 讚! | 东京婉奕 |
作者: 北海仙仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-22 23:50:27 評論於 Hello, I want to ask how to successfully register for this journal's submission account? I cannot receive the registration email at all, so I can't complete the login(0) 讚! | 北海仙仪 |
作者: 北海仙仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-22 17:55:29 評論於 Hello, I want to ask how to successfully register for the submission account of this journal? I can't receive the registration email at all, so I can't complete the login(0) 讚! | 北海仙仪 |
作者: 北海仙仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-22 17:28:32 評論於 Hello, did you submit the article in the end? I can't receive the verification email when I go to the magazine's official website, so I don't know where to start submitting(0) 讚! | 北海仙仪 |
作者: 北海仙仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-22 12:46:06 評論於 Hello, I would like to ask how to successfully register for the submission account of this journal. I haven't received the registration email at all, so I can't complete the login(0) 讚! | 北海仙仪 |
作者: 蓬莱山咏思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 22:37:52 評論於 Is the editor assigned still waiting to be reviewed by the reviewer? Will rushing the paper leave a bad impression?(0) 讚! | 蓬莱山咏思 |
作者: 蓬莱山咏思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 21:58:15 評論於 How are you doing, my friend?(0) 讚! | 蓬莱山咏思 |
作者: 蓬莱山咏思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 21:55:53 評論於 Is the editor assigned not yet in the hands of the reviewers?(0) 讚! | 蓬莱山咏思 |
作者: 蓬莱山咏思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 20:55:38 評論於 Friend, how are you doing?(0) 讚! | 蓬莱山咏思 |
作者: 蓬莱山咏思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 14:19:17 評論於 Have you accepted it? Has the assigned editor not reached the reviewer yet? Would a deadline reminder result in rejection?(0) 讚! | 蓬莱山咏思 |
作者: 蓬莱山咏思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 11:17:00 評論於 Is the editor assigned still not in the hands of the reviewer?(0) 讚! | 蓬莱山咏思 |
作者: 东京振安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-02 17:17:56 評論於 I am also like this, how do you change behind?(0) 讚! | 东京振安 |
作者: 气甲娅童 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-14 22:59:18 評論於 I used Word to put the table inside, and the Figure separately(0) 讚! | 气甲娅童 |
作者: 晏然来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-14 18:55:34 評論於 Hello, I would like to ask how to submit an article to this magazine. I am having trouble uploading it. Is a LaTex document required?(0) 讚! | 晏然来了 |
作者: 晏然来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-14 17:35:26 評論於 Exciting comments, you need to log in to view(0) 讚! | 晏然来了 |
作者: 气甲娅童 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-20 15:32:08 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Emphasized Research Direction: Lung Adenocarcinoma Experience Sharing: Initially submitted to this journal, only checked the comments after submission, thinking it would take a long time... But overall the speed was still okay 12.22.14 Received 12.15 Submitted for review 1.24 First review returned, minor revisions 2.2 Revised 2.18 Second review returned 2.19 Accepted 2.25 Published #lung cancer#(0) 讚! | 气甲娅童 |
作者: 七星同方 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-24 17:43:38 評論於 Could you please tell me how things have changed since then?(0) 讚! | 七星同方 |
作者: 七星同方 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-24 13:44:19 評論於 Could you please tell me what changes have occurred in the meantime?(0) 讚! | 七星同方 |
作者: 黑沙箫笛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-18 12:39:13 評論於 Review speed: 12.0 | Submission hit rate: 50.0 Emphasis on research direction: Pulmonary cysts Experience sharing: It took 4 months from submission to the first review, and only one reviewer's comments were received. It has been three months since the second review, despite multiple reminders. Just now, another reviewer has been assigned. The efficiency of this journal is really low, so be cautious when submitting articles(0) 讚! | 黑沙箫笛 |
作者: 风神文宣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-11 21:39:57 評論於 Help me, please!(0) 讚! | 风神文宣 |
作者: 风神文宣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-11 18:21:49 評論於 Regretting it, it's better not to switch to this(0) 讚! | 风神文宣 |
作者: 风神文宣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-11 13:50:10 評論於 Recommended by other magazines to republish in this magazine. BMC is notoriously slow, and now I regret it a little(0) 讚! | 风神文宣 |
作者: 北马美美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-31 13:45:48 評論於 It took me a total of 13 months(0) 讚! | 北马美美 |
作者: 海白来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-25 12:19:37 評論於 Brothers, is it still so slow now?? It’s been 5 days and the editor hasn’t been assigned yet(0) 讚! | 海白来了 |
作者: 爱景小郎君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-06 13:26:54 評論於 Submitted for nine months and finally rejected. In the first round of review, two reviewers provided friendly comments. The editor requested a major revision. After revisions were made, the editor could not locate the original reviewers. Therefore, a new reviewer was invited, who seemed to be Chinese. The questions raised by this new reviewer were extremely harsh and somewhat amateurish. It seems that Chinese people tend to make things difficult for other Chinese. Since the previous two reviewers could not be found, the editor rejected the submission based on the new reviewer's comments. It's all about luck when submitting papers. If you encounter reviewers who are not competent and provide random comments, it's just bad luck(0) 讚! | 爱景小郎君 |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us